These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 6090847

  • 1. Opioid control of the ruminant stomach motility: functional importance of mu, kappa and delta receptors.
    Ruckebusch Y, Bardon T, Pairet M.
    Life Sci; 1984 Oct 22; 35(17):1731-8. PubMed ID: 6090847
    [Abstract] [Full Text] [Related]

  • 2. Opioid receptor agonists in the rabbit colon: comparison of in vivo and in vitro studies.
    Pairet M, Ruckebusch Y.
    Life Sci; 1984 Oct 15; 35(16):1653-8. PubMed ID: 6148681
    [Abstract] [Full Text] [Related]

  • 3. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ, Nunan L, Porreca F.
    J Pharmacol Exp Ther; 1987 Oct 15; 243(1):234-40. PubMed ID: 2822899
    [Abstract] [Full Text] [Related]

  • 4. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.
    Ramme D, Illes P.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan 15; 332(1):57-61. PubMed ID: 2869418
    [Abstract] [Full Text] [Related]

  • 5. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA, Burks TF.
    J Pharmacol Exp Ther; 1988 Feb 15; 244(2):456-62. PubMed ID: 2831341
    [Abstract] [Full Text] [Related]

  • 6. TENA, a selective kappa opioid receptor antagonist.
    Portoghese PS, Takemori AE.
    Life Sci; 1985 Feb 25; 36(8):801-5. PubMed ID: 2983171
    [Abstract] [Full Text] [Related]

  • 7. Mu and delta, but not kappa, opioid agonists induce contractions of the canine small intestine in vivo.
    Vaught JL, Cowan A, Jacoby HI.
    Eur J Pharmacol; 1985 Feb 12; 109(1):43-8. PubMed ID: 2859995
    [Abstract] [Full Text] [Related]

  • 8. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR, Makhlouf GM.
    Am J Physiol; 1991 Jan 12; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [Abstract] [Full Text] [Related]

  • 9. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
    Tavani A, Petrillo P, La Regina A, Sbacchi M.
    J Pharmacol Exp Ther; 1990 Jul 12; 254(1):91-7. PubMed ID: 2164103
    [Abstract] [Full Text] [Related]

  • 10. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.
    Takemori AE, Ho BY, Naeseth JS, Portoghese PS.
    J Pharmacol Exp Ther; 1988 Jul 12; 246(1):255-8. PubMed ID: 2839664
    [Abstract] [Full Text] [Related]

  • 11. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG, Fields HL, Lee NM.
    J Pharmacol Exp Ther; 1986 Sep 12; 238(3):1039-44. PubMed ID: 3018217
    [Abstract] [Full Text] [Related]

  • 12. Mu, but not kappa, opioid agonists induce contractions of the canine small intestine ex vivo.
    Hirning LD, Porreca F, Burks TF.
    Eur J Pharmacol; 1985 Feb 12; 109(1):49-54. PubMed ID: 2986990
    [Abstract] [Full Text] [Related]

  • 13. Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit.
    Jackisch R, Geppert M, Illes P.
    J Neurochem; 1986 Jun 12; 46(6):1802-10. PubMed ID: 2871130
    [Abstract] [Full Text] [Related]

  • 14. Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
    Gué M, Junien JL, Bueno L.
    J Pharmacol Exp Ther; 1989 Sep 12; 250(3):1006-10. PubMed ID: 2550612
    [Abstract] [Full Text] [Related]

  • 15. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ, Takemori AE.
    J Pharmacol Exp Ther; 1983 Mar 12; 224(3):525-30. PubMed ID: 6131119
    [Abstract] [Full Text] [Related]

  • 16. Comparison of analgesic potencies of mu, delta and kappa agonists locally applied to various CNS regions relevant to analgesia in rats.
    Satoh M, Kubota A, Iwama T, Wada T, Yasui M, Fujibayashi K, Takagi H.
    Life Sci; 1983 Mar 12; 33 Suppl 1():689-92. PubMed ID: 6141508
    [Abstract] [Full Text] [Related]

  • 17. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S, Kim HS, Wood PL.
    Brain Res; 1987 Dec 01; 435(1-2):220-6. PubMed ID: 2892574
    [Abstract] [Full Text] [Related]

  • 18. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA.
    J Pharmacol Exp Ther; 1990 Jul 01; 254(1):13-22. PubMed ID: 2164087
    [Abstract] [Full Text] [Related]

  • 19. Opioid receptor subtypes involved in the central inhibition of urinary bladder motility.
    Dray A, Metsch R.
    Eur J Pharmacol; 1984 Sep 03; 104(1-2):47-53. PubMed ID: 6094211
    [Abstract] [Full Text] [Related]

  • 20. Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.
    Locke KW, Gorney B, Cornfeldt M, Fielding S.
    Psychopharmacology (Berl); 1989 Sep 03; 99(4):492-6. PubMed ID: 2556726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.